hasIndication
P23161
predicate
Indicates that one entity (typically a product, treatment, or intervention) is intended, approved, or suitable for use in addressing, preventing, or managing a particular condition, purpose, or circumstance.
All labels observed (15)
| Label | Occurrences |
|---|---|
| indication | 265 |
| hasIndication canonical | 169 |
| approvedForIndication | 14 |
| hasIndicationDetail | 6 |
| hasHealthIndication | 5 |
| hasIndicationType | 5 |
| hasPrimaryIndication | 5 |
| indicationType | 5 |
| hasDrugIndication | 3 |
| hasIndicationRegion | 3 |
| hasFDALabelIndication | 2 |
| indicationSubtype | 2 |
| isIndicatedWhen | 2 |
| hasIndicationStatus | 1 |
| leadProductIndication | 1 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: hasIndication
Generated description
Indicates that one entity (typically a product, treatment, or intervention) is intended, approved, or suitable for use in addressing, preventing, or managing a particular condition, purpose, or circumstance.
Sample triples (488)
| Subject | Object |
|---|---|
| COVID-19 vaccines | prevention of COVID-19-related death via predicate surface "indication" ⓘ |
| CLARITY AD | early Alzheimer’s disease via predicate surface "indication" ⓘ |
| CLARITY AD | mild cognitive impairment due to Alzheimer’s disease via predicate surface "indication" ⓘ |
| CLARITY AD | mild Alzheimer’s disease dementia via predicate surface "indication" ⓘ |
| Study 301 |
Alzheimer's disease
via predicate surface "indication"
ⓘ
surface form:
Alzheimer’s disease
|
| EMERGE (Study 302) |
Alzheimer's disease
via predicate surface "indication"
ⓘ
surface form:
Alzheimer’s disease
|
| ENGAGE (Study 301) | early Alzheimer’s disease via predicate surface "indication" ⓘ |
| ENGAGE (Study 301) | mild cognitive impairment due to Alzheimer’s disease via predicate surface "indication" ⓘ |
| ENGAGE (Study 301) | mild Alzheimer’s disease dementia via predicate surface "indication" ⓘ |
| Zepbound | chronic weight management via predicate surface "indication" ⓘ |
| Zepbound | obesity in adults via predicate surface "indication" ⓘ |
| Zepbound | overweight in adults with weight-related comorbidities via predicate surface "indication" ⓘ |
| Verzenio | hormone receptor–positive breast cancer via predicate surface "indication" ⓘ |
| Verzenio | HER2-negative breast cancer via predicate surface "indication" ⓘ |
| Verzenio | advanced breast cancer via predicate surface "indication" ⓘ |
| Verzenio | metastatic breast cancer via predicate surface "indication" ⓘ |
| Verzenio | early breast cancer at high risk of recurrence via predicate surface "indication" ⓘ |
| Taltz | treatment of adults with moderate to severe plaque psoriasis ⓘ |
| Taltz | treatment of active psoriatic arthritis ⓘ |
| Taltz | treatment of active ankylosing spondylitis ⓘ |
| Taltz | treatment of non-radiographic axial spondyloarthritis with objective signs of inflammation ⓘ |
| Emgality | prevention of migraine in adults via predicate surface "indication" ⓘ |
| Emgality | treatment of episodic cluster headache in adults via predicate surface "indication" ⓘ |
| Emgality | treatment of migraine via predicate surface "indication" ⓘ |
|
Loxo Oncology (acquired)
surface form:
Loxo Oncology
|
NTRK gene fusion-positive solid tumors via predicate surface "leadProductIndication" ⓘ |
| risdiplam | treatment of spinal muscular atrophy in pediatric patients via predicate surface "indication" ⓘ |
| risdiplam | treatment of spinal muscular atrophy in adult patients via predicate surface "indication" ⓘ |
|
edaravone
surface form:
Edaravone
|
treatment of ALS in adults via predicate surface "indication" ⓘ |
| Waylivra | familial chylomicronemia syndrome via predicate surface "indication" ⓘ |
| Waylivra | orphan disease treatment via predicate surface "indicationType" ⓘ |
| levodopa | management of motor symptoms in Parkinson's disease via predicate surface "indication" ⓘ |
| MabThera | non-Hodgkin lymphoma via predicate surface "indication" ⓘ |
| MabThera | diffuse large B-cell lymphoma via predicate surface "indication" ⓘ |
| MabThera | follicular lymphoma via predicate surface "indication" ⓘ |
| MabThera | chronic lymphocytic leukemia via predicate surface "indication" ⓘ |
| MabThera | rheumatoid arthritis via predicate surface "indication" ⓘ |
| MabThera | granulomatosis with polyangiitis via predicate surface "indication" ⓘ |
| MabThera | microscopic polyangiitis via predicate surface "indication" ⓘ |
| MabThera | certain autoimmune diseases via predicate surface "indication" ⓘ |
| faricimab | treatment of neovascular (wet) age-related macular degeneration via predicate surface "indication" ⓘ |
| faricimab | treatment of diabetic macular edema via predicate surface "indication" ⓘ |
| aflibercept | neovascular age-related macular degeneration via predicate surface "indication" ⓘ |
| aflibercept | wet age-related macular degeneration via predicate surface "indication" ⓘ |
| aflibercept | diabetic macular edema via predicate surface "indication" ⓘ |
| aflibercept | macular edema following retinal vein occlusion via predicate surface "indication" ⓘ |
| aflibercept | central retinal vein occlusion via predicate surface "indication" ⓘ |
| aflibercept | branch retinal vein occlusion via predicate surface "indication" ⓘ |
| aflibercept | myopic choroidal neovascularization via predicate surface "indication" ⓘ |
| aflibercept | metastatic colorectal cancer via predicate surface "indication" ⓘ |
|
Persona knee system
surface form:
Persona Knee System
|
painful osteoarthritis of the knee via predicate surface "indication" ⓘ |